Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 Million Colombians
Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 Million Colombians Starting January 1st, 2022, every insurance provider in Colombia, is now mandated to cover the costs of high and low THC medical cannabis prescriptions Significantly...
Valens Company Announces Strategic Agreements with PMI Mexico
The Valens Company Announces Strategic Agreements with PMI Mexico • Valens to serve as exclusive supplier of CBD for PMI’s clinical trial, which will measure anti-inflammatory applications of medical-grade, nano-water emulsified CBD oil• Valens will manufacture...
Malta to Become First EU Country to Legalize Cannabis
Malta to Become First EU Country to Legalize Cannabis Malta will become the first EU country to legalise the cultivation and possession of cannabis for personal use, as the continent undergoes a wave of change to its drug laws this week. Possession of up to seven...
Mexico Supreme Court Allows First Cannabis Company to Operate
Mexico Supreme Court Allows First Cannabis Company to Operate The Mexican Supreme Court has voted in favor of Xebra’s subsidiary Desart MX, SA de CV becoming the only company in Mexico that will be authorized to legally import cannabis seeds, cultivate cannabis,...
With Colombia on the Rise is PharmaCielo Stock a Buy?
In an increasingly globalized cannabis market, Colombia continues to make headlines. In fact, this July, Colombian President Ivan Duque gave the Colombian cannabis industry a huge bump by signing a directive to allow for the export of dried cannabis flower. Several...
CanninPlus with Trading Alerts!
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$99 / month after 7-day trial.
Still unsure? Schedule demo at [email protected]
or call 720-254-1374
The Best Cannabis Stocks for 2022
-
Cannin Report Q2 2021
$49.00
-
Cannin Report Q1 2021
$29.00
-
The Cannin Report 2020
$19.00
-
FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick
$0.00
-
The Cannin Report Q4 2019
$29.00
